Latest Industry Insights
Exploring the Technology Behind a Blood Test for Alzheimer's Disease
Technology Networks recently spoke to Quanterix's Kevin Hrusovsky to hear more about how the company's technology is being applied in the pursuit of a biomarker for Alzheimer's disease, a progressive neurodegenerative condition for which diagnosis often occurs after the onset of symptoms.
Towards a Deeper Understanding of the Proteomic Landscape
At a recent London Proteomics Discussion Group Meeting, Professor Roman Fischer kicked off the event by addressing the apparent "failure" of proteomics to deliver new clinical biomarkers thus far. Technology Networks sat down with Fischer to discuss spatial proteomics, and to expand on some of the key aspects of his research.
Can Teletherapy Help People With OCD During the COVID-19 Pandemic?
Whilst the coronavirus pandemic and associated lockdown has taken a toll on everyone’s mental health, the burden has been especially heavy for people living with obsessive compulsive disorder (OCD). We spoke to NOCD’s founder Stephen Smith, who has experienced the crippling impact of OCD in his own life, on how his remote counselling service could help people with OCD during the pandemic.
Taking a Closer Look at Trends in Microscopy
With advances in cellular and tissue-based imaging, researchers are able to peel back the layers on new challenges and test hypotheses to solve more problems. We heard about some of the advancements being made in the field of confocal microscopy.
The Startup Turning Yeast Into Psychedelics
Technology Networks recently spoke with Nick Milne, co-founder and CSO at Octarine to learn more about what science says on the therapeutic benefits of psychedelic compounds, why a bio-based approach for manufacturing is advantageous and the challenges associated.
Developing the World's First Single Molecule Protein Sequencer
Jagannath Swaminathan is the co-founder of Erisyon and a researcher at the Marcotte Lab at the University of Texas Austin. In this interview, we discuss the concept of next-generation protein sequencing, clinical proteomics and the critical role of protein sequencing in the fight against COVID-19.
Less Time Managing Inventory, More Time at the Bench? Yes Please
Lab efficiency is critical to speeding up development processes, yet many researchers find they spend more time managing consumables data than working at the bench. Lab informatics is one solution to this problem.
Advancing ALS Research With Omics Analysis Technology
Clinical trials produce a massive amount of medically relevant and highly sensitive data. Leveraging such data could make a difference to efforts to create more personalized, effective medicines. We talked to Medidata’s Sheila Diamond to find out more.
Going Label-Free: The Future of Metabolomics Imaging
The study of brain tumors using real-time imaging of the brain in live disease models is critical for elucidating disease mechanisms and developing novel treatment strategies. Such research requires full characterization of healthy and disease phenotypes using a multi-omics analysis, as described in this blog.
Exploring the Therapeutic Potential of Psychedelics
Technology Networks recently interviewed Ronan Levy, Founder and Executive Chairman of Field Trip Psychedelics, Inc. to find out more about the therapeutic potential of psychedelics and hear about the drugs undergoing clinical investigation.